Xu GB et al.
2013
|
35/35
|
37/33
|
50. 3 ±7.9
|
biliary tract diseases:37
excessive drinking and eating:5
traumatic injury:5
unknown cause:5
|
NR
|
APACHE-II score,CRP,Length of ICU stay and mortality rate
|
Liu XS et al. 2017
|
22/53
|
T:14/8
C:31/22
|
T:(52.1±11.2)
C:(50.7±13.4)
|
NR
|
24h
72h
|
HR, urine volume, K+,BUN,Scr,CRP,TNF-α, IL-6
|
Wang
XQ et al. 2019
|
35/25
|
T:22/13
C:18/7
|
T:(40.5±9.5)
C:(41.1±9.5)
|
hyperlipidemia
|
NR
|
Treatment effect,TG,
CRP,blood
amylase and urine amylase
|
Hui WJ et al. 2017
|
60/60
|
T:32/28
C:30/30
|
T:(37.6±5.4)
C:(38.1±5.6)
|
NR
|
NR
|
Treatment effect, blood amylase,
TNF-α,
IL-1
|
Zou YD et al. 2017
|
31/31
|
T:18/13
C:16/15
|
T:(43.02±4.51)
C:(43.85±3.91)
|
NR
|
NR
|
Treatment effect,
blood
amylase, CRP, IL-6,PO2
|
Deng ZY et al. 2014
|
32/32
|
46/18
|
41.7
|
biliary panScreatitis:47
alcoholic panScreatitis:12
unknown cause:5
|
NR
|
APACHE-II score,TNF-α, endotoxin, IL-6, IL-18, mortality rate
|
Peng
Y et al. 2019
|
22/20
|
25/27
|
37
|
biliary tract diseases:18
excessive drinking and eating:11
mixed cause:10
idiopathic cause:3
|
NR
|
IL-6,TNF-α, blood amylase
|
Zhong X et al. 2017
|
37/37
|
T:23/14
C:21/16
|
T:(56.5±4.3)
C:(55.8±4.4)
|
T: biliary tract diseases:14
excessive drinking and eating:8
alcoholism:9
other cause:6
C: biliary tract diseases:15
excessive drinking and eating:7
alcoholism:8
other cause:7
|
72h
|
Treatment effect, APACHE-II score,ALB,ALT,
24h
urine output ,BUN,Scr
|
Peng
B et al. 2019
|
41/41
|
T:27/14
C:26/15
|
T:(43.7±8.6)
C:(44.3±8.5)
|
T:
biliary tract diseases:19
hyperlipidemia:8
alcoholism:10
other cause:4
C: biliary tract diseases:17
hyperlipidemia:9
alcoholism:10
other cause:5
|
6h
12h
24h
|
PCT,CRP, D-dimer, blood lipase,blood amylase,PLT
|
Zou
H.2018
|
22/15
|
T:20/2
C:4/11
|
T:(39.23±6.36)
C:(38.27±6.77)
|
hyperlipidemia
|
48h
|
Treatment effect,TG,TCH, blood lipase,blood amylase,CRP,Scr
|
Wang Y et al. 2018
|
36/36
|
T:24/12
C:25/11
|
T:(47.4±13.6)
C:(46.7±13.2)
|
T: biliary tract diseases:19
excessive drinking and eating:7
alcoholism:10
other cause:4
C:
biliary
tract diseases:11
excessive drinking and eating:10
alcoholism:6
other cause:7
|
24h
72h
|
CRP, PCT, Scr, BUN, Ca, APACHE-II score
|
Ni ZH.2013
|
29/22
|
T:21/8
C:10/12
|
T:(47.3±14)
C:(47.18±12.24)
|
T: biliary tract diseases:8
excessive drinking and eating:8
alcoholism:8
unknown cause:5
C:
biliary
tract diseases:7
excessive drinking and eating:3
alcoholism:5
unknown cause:7
|
24h
48h
72h
|
24h
urine output,PH,PO2,PCO2,
BUN,SCr,Na,K,Ca,ALT,WBC, Treatment effect
|
Li YN et al. 2002
|
20/17
|
25/12
|
43.3
|
biliary tract diseases:7
excessive eating:6
alcoholism:10
unknown cause:3
Trauma:2
|
7days
|
Treatment effect,
blood
amylase,SCr,TP,ALB,GLU,Ca
|
Chen DJ et al.2018
|
49/49
|
T:26/23
C:24/25
|
T:(45.72±6.34)
C:(46.52±7.35)
|
NR
|
12h
24h
36h
|
HR,
24h
urine
output,PO2,PCO2,PH,Ca,K,Na,BUN,SCr,GLU,ALT,PLT,WBC
|
Tian JX et al.2015
|
60/60
|
T:35/25
C:36/24
|
T:(42.9±12.5)
C:(43.8±11.7)
|
NR
|
72h
|
APACHE-II score, blood amylase,ALB,TP
|
Li Q.2020
|
27/27
|
T:15/12
C:14/13
|
T:(45.39±5.56)
C:(45.66±5.79)
|
T: biliary calculi:4
alcoholism:7
sphincter dysfunction of hepatopancreatic ampulla:3
hyperlipidemia:3
excessive drinking and eating:10
C: biliary calculi:3
alcoholism:8
sphincter dysfunction of hepatopancreatic ampulla:4
hyperlipidemia:3
excessive drinking and eating:9
|
72h
|
APACHE-II score, Treatment effect
|
Xiao XP.2014
|
17/13
|
18/12
|
48±5
|
NR
|
24h
48h
72h
|
Treatment effect,TNF-α
|
Zhu JG et al.2007
|
17/14
|
T:10/7
C:9/5
|
T:(49.93±10.3)
C:(51.05±11.10)
|
NR
|
NR
|
HR,PCT,CRP, Treatment effect
|
Wang LY.2017
|
45/45
|
T:28/17
C:25/20
|
T:(46.25±5.63)
C:(48.53±6.24)
|
NR
|
NR
|
APACHE-II score,CRP,PCT, TNF-α
|
Yang H.2013 |
25/25 |
27/23 |
43.25 |
NR |
NR |
APACHE-II score,SCr,TG,
blood amylase ,PO2,ALT |
Li KY.2016
|
30/30
|
T:20/10
C:16/14
|
NR
|
NR
|
24h
72h
7days
|
HR,APACHE-II score,CRP,PCT, TNF-α,BUN,SCr,ALT,AST
|
Cui WY et al.2017
|
16/11
|
T:10/6
C:4/7
|
T:(49.91±24.23)
C:(50.63±14.30)
|
T: biliary tract diseases:8
alcoholism:2
hyperlipidemia:5
other cause:1
C: biliary tract diseases:7
alcoholism:2
hyperlipidemia:2
other cause:0
|
24h
72h
|
SCr,WBC,CRP
|
Chen FS.2020 |
45/45 |
45/45 |
45±6.7 |
NR |
48h |
SCr,PCT,TG,TB,pH,PO2,HR, blood amylase |
Xu F et al.2019
|
32/32
|
T:19/13
C:18/14
|
T:(42.05±3.93)
C:(42.68±2.95)
|
T: biliary tract diseases:14
alcoholism:13
hyperlipidemia:5
C: biliary tract diseases:15
alcoholism:12
hyperlipidemia:5
|
72h
|
HR,BUN,SCr,ALT,AST, blood amylase
|
Zhu CZ.2016
|
40/40
|
T:25/15
C:28/12
|
T:(45.2±8.5)
C:(44.9±7.9)
|
NR
|
72h
|
PO2,PCO2,WBC,HR
|
Gao N. et al.2018
|
46/46
|
T:24/22
C:22/24
|
T:(38.87±6.47)
C:(39.13±6.56)
|
T:
alcoholism:16
hyperlipidemia:20
cholelithiasis:7
other cause:3
C: alcoholism:14
hyperlipidemia:18
cholelithiasis:9
other cause:5
|
6h
12h
24h
|
PCT,CRP,IL-17,IL-6,HMGB1,D-dimer
|
Xu JM. et al.2017
|
25/11
|
T:24/22
C:22/24
|
NR
|
NR
|
7days
|
blood
amylase,ALT,SCr,CRP,Hb,ALB,Ca,WBC,INR
|
Chen X et al.2019
|
32/28
|
T:20/12
C:18/10
|
T:(54.32±10.65)
C:(58.94±9.02)
|
NR
|
7days
|
ALT,AST, TBIL,ALB,WBC,RBC,PLT,BUN,SCr,
blood
and urine amylase
|
Zhang X.et al.2016 |
8/14 |
14/8 |
54±14 |
NR |
48h |
APACHE-II
score,TG,CRP, Treatment effect |
Wang LF.2020
|
15/15
|
T:8/7
C:7/8
|
T:(46.7±11.4)
C:(46.8±11.5)
|
NR
|
72h
|
Na,Ca,K,BUN,Scr,WBC,PLT,ALT,TBIL,HR,
24h
urine output
|
Liu MX.et al.2011 |
15/15 |
10/16 |
53±16 |
NR |
48h |
APACHE-II
score,TG,CRP,
blood
and urine amylase, Treatment effect |
Xu JY.2013 |
12/20 |
23/9 |
47.5 |
hyperlipidemia |
48h |
Treatment
effect,
APACHE-II
score,TG,CRP,blood
and urine amylase |
Wu SK.2015
|
28/30
|
T:18/10
C:19/11
|
T:(67.5±10.3)
C:(69.5±11.3)
|
T:
alcoholism:8
cholelithiasis:10
other cause:10
C: alcoholism:10
cholelithiasis:12
other cause:8
|
NR
|
Treatment effect, the time taken for clinical indicators to return to
normal
|
Xu Y.et al.2009
|
30/30
|
T:20/10
C:19/11
|
T:(30±10.5)
C:(43.1±10.5)
|
T: alcoholism:6
high-fat diet:6
history of biliary tract infection:5
excessive drinking and eating:12
unknown cause:1
C: alcoholism:6
high-fat diet:5
history of biliary tract infection:8
excessive drinking and eating:9
unknown cause:2
|
24h
48h
72h
|
APACHE-II score
|
Wei R.2016
|
40/40
|
NR
|
60.3±1.8
|
alcoholism:37
cholelithiasis:43
|
NR
|
APACHE-II score,HR,MAP,CRP,BUN,AST
|
Tian GX.2016
|
60/60
|
T:32/28
C:30/30
|
T:(37.6±5.4)
C:(38.1±5.6)
|
NR
|
NR
|
Treatment effect,IL-1,TNF-α,blood amylase
|
Wan CS.2017
|
60/60
|
NR
|
NR
|
T: alcoholism:18
cholelithiasis:13
excessive drinking and eating:24
unknown cause:5
C: alcoholism:20
cholelithiasis:15
excessive drinking and eating:21
unknown cause:4
|
72h
|
Na,K,Ca,BUN,SCr,WBC,PLT,ALT,TBIL,HR, 24h urine output
|
Wang YF.et al.2017
|
12/20
|
T:7/5
C:14/6
|
T:42
C:41
|
hyperlipidemia
|
NR
|
HR,SCr,TG,CRP,IL-1,TNF-α,GLU,
APACHE-II score
|
Ji HL.et al.2011
|
36/38
|
T:23/13
C:25/13
|
T:57
C:54
|
NR
|
NR
|
CRP,APN, Treatment effect
|
Li LL.2018
|
40/40
|
T:23/17
C:25/15
|
T:(43.26±8.87)
C:(42.17±8.67)
|
NR
|
72h
|
IL-6,TNFα,SCr,BUN, Treatment effect
|
Li YP.2014
|
13/13
|
T:9/4
C:9/4
|
T:51.8
C:56.5
|
alcoholism:8
cholelithiasis:3
excessive drinking and eating:10
hyperlipidemia:2 surgery:1 hepatopancreatic ampulla sphincter
dysfunction:2
|
7days
|
IL-6,TNF-α,WBC,HR,CRP,PH,PO2 ,Treatment effect
|
Li QB.et al.2009
|
19/19
|
T:12/7
C:14/5
|
T:(44.3±19.5)
C:(45.4±18.7)
|
T: cholelithiasis:10
excessive drinking and eating:5
trauma:2
unknown cause:2
C: cholelithiasis:13
excessive drinking and eating:6
|
72h
|
IL-6,TNF-α,
APACHE-II
score,PO2,PH,
Treatment
effect
|
Hu W.et al.2001
|
10/10
|
T:7/3
C:7/3
|
T:(56.8±15.4)
C:(59.7±13.2)
|
NR
|
7days
|
IL-6,TNF-α,IL-1β,APACHE-II
score,Treatment effect
|
Shen Q.et al.2016
|
43/35
|
47/31
|
47.3±14.8
|
cholelithiasis:23
excessive drinking and eating:13
alcoholism:18
hyperlipidemia:15
unknown cause:9
|
72h
|
APACHE-II
score, TNF-α,CRP, Treatment effect, blood amylase
|
Sun JH.et al.2018
|
39/39
|
T:22/17
C:24/15
|
T:(40.4±5.9)
C:(43.6±6.9)
|
NR
|
24h
|
HR,BUN,SCr,ALT,AST, blood amylase
|
Wu LM.et al.2013
|
40/18
|
T:17/23
C:11/7
|
T:(50.5±9.4)
C:(51.4±7.8)
|
cholelithiasis:43
hyperlipidemia:13
other cause:2
|
72h
|
APACHE-II
score,TBIL,SCr,Ca,GLU,WBC
|
Liu
JQ.2019
|
50/50
|
T:27/23
C:26/24
|
T:(42.3±6.5)
C:(42.1±7.1)
|
T: cholelithiasis:11
hyperlipidemia:17
alcohol abuse:14
other cause:8
C: cholelithiasis:13
hyperlipidemia:15
alcohol abuse:16
other cause:6
|
72h
|
PO2,WBC,MAP,Na,K,PCT,CRP
|
Hou QC.et al.2018
|
36/36
|
T:20/18
C:22/16
|
T:(42.3±6.5)
C:(45.6±3.6)
|
NR
|
NR
|
APACHE-II score,CRP,PCT,TNF-α
|
Zhou JY.2015
|
23/23
|
T:13/10
C:12/11
|
T:(46.7±8.7)
C:(47.2±9.1)
|
T: cholelithiasis:12
hyperlipidemia:4
alcohol abuse:6
other cause:1
C: cholelithiasis:10
hyperlipidemia:4
alcohol abuse:7
other cause:2
|
NR
|
CRP,PCT,SCr,BUN,ALT,ALB
|
Yu ZD.et al.2015
|
25/25
|
T:18/7
C:12/13
|
NR
|
biliary tract :25
cholelithiasis with cholecystitis:10
high-fat diet:7
alcohol abuse:3
overeating:3
unknown cause:2
|
NR
|
APACHE-II score,CRP
|
Wang XM.2016
|
50/50
|
T:28/22
C:26/24
|
T:(48.5±8.4)
C:(45.4±6.2)
|
NR
|
NR
|
PO2,PH
|
Tang W.et al.2017
|
35/35
|
T:21/14
C:20/15
|
T:(45.6±13.1)
C:(46.7±12.9)
|
T: alcoholism:8
cholelithiasis:7
excessive drinking and eating:6
hyperlipidemia:6
hepatopancreatic ampulla sphincter dysfunction:8
C: alcoholism:5
cholelithiasis:9
excessive drinking and eating:6
hyperlipidemia:7
hepatopancreatic ampulla sphincter dysfunction:8
|
48h
|
TG,TB,SCr,PCT,PH,PO2,AMS
|
Peng Y.et al.2017 |
40/40 |
48/32 |
34 |
NR |
NR |
Il-1β,TNF-α,PCT,AMS,HR, APACHE-II score, Treatment
effect |